TNF-α Signals Through PKCζ/NF-κB to Alter the Tight Junction Complex and Increase Retinal Endothelial Cell Permeability
Open accessThe DOI matches its Crossref record; 55 of the 57 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Tumor necrosis factor-α (TNF-α) and interleukin-1 beta (IL-1β) are elevated in the vitreous of diabetic patients and in retinas of diabetic rats associated with increased retinal vascular permeability. However, the molecular mechanisms underlying retinal vascular permeability induced by these cytokines are poorly understood. In this study, the effects of IL-1β and TNF-α on retinal endothelial cell permeability were compared and the molecular mechanisms by which TNF-α increases cell permeability were elucidated. RESEARCH DESIGN AND METHODS: Cytokine-induced retinal vascular permeability was measured in bovine retinal endothelial cells (BRECs) and rat retinas. Western blotting, quantitative real-time PCR, and immunocytochemistry were performed to determine tight junction protein expression and localization. RESULTS: IL-1β and TNF-α increased BREC permeability, and TNF-α was more potent. TNF-α decreased the protein and mRNA content of the tight junction proteins ZO-1 and claudin-5 and altered the cellular localization of these tight junction proteins. Dexamethasone prevented TNF-α–induced cell permeability through glucocorticoid receptor transactivation and nuclear factor-kappaB (NF-κB) transrepression. Preventing NF-κB activation with an inhibitor κB kinase (IKK) chemical inhibitor or adenoviral overexpression of inhibitor κB alpha (IκBα) reduced TNF-α–stimulated permeability. Finally, inhibiting protein kinase C zeta (PKCζ) using both a peptide and a novel chemical inhibitor reduced NF-κB activation and completely prevented the alterations in the tight junction complex and cell permeability induced by TNF-α in cell culture and rat retinas. CONCLUSIONS: These results suggest that PKCζ may provide a specific therapeutic target for the prevention of vascular permeability in retinal diseases characterized by elevated TNF-α, including diabetic retinopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These molecules function to promote leukocyte recruitment, adhesion, and infiltration through the blood-retinal barrier, ultimately resulting in a breakdown of retinal immune privilege.15,16”
From Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina (2021) · cites this paper as [15]
Experimental — accuracy not yet measuredIn the citing paper
“Furthermore, neurovascular damage induced by the peripheral myeloid cells, pro-inflammatory cytokines, and the dysregulation of the complement pathways could be a further potential mechanism of action [36,37,38].”
From C-Reactive protein as a biomarker for major depressive disorder? (2022) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860 · cited 1×
“0 RQ software and the 2 Ct analysis method (31), with glyceraldehyde-3-phosphate dehydrogenase (Bt03210919_g1) as the endogenous control.”
MethodBatlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice
Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M., & Tsukita, S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302070 · Cited by 1,917 · cited 1×
“Gene deletion studies have shown claudin-5 to be essential for blood–brain barrier function (25), and likely for the BRB as well.”
BackgroundSignalling to and from tight junctions
Matter, K., & Balda, M. S. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1055 · Cited by 884 · cited 1×
“Tight junctions are composed of a combination of more than 40 proteins including the transmembrane proteins occludin, the claudin family, and the junction adhesion molecule (JAM) family, several peripheral membrane-associated proteins, including members of the zonula occludens (ZO) family, and several regulatory prote…”
BackgroundUmeda, K., Ikenouchi, J., Katahira-Tayama, S., Furuse, K., Sasaki, H., Nakayama, M., Matsui, T., Tsukita, S., Furuse, M., & Tsukita, S. (2006) · Cell · doi:10.1016/j.cell.2006.06.043 · Cited by 823 · cited 1×
“Recent studies demonstrated that ZO proteins are essential for the formation and organization of tight junction complex assembly (26,27).”
BackgroundMiyamoto, K., Khosrof, S., Bursell, S.-E., Rohan, R., Murata, T., Clermont, A. C., Aiello, L. P., Ogura, Y., & Adamis, A. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10836 · Cited by 788
Antonetti, D. A., Barber, A. J., Bronson, S. K., Freeman, W. M., Gardner, T. W., Jefferson, L. S., Kester, M., Kimball, S. R., Krady, J. K., LaNoue, K. F., et al. (2006) · Diabetes · doi:10.2337/db05-1635 · Cited by 746
Self-citationAntonetti, D. A., Barber, A. J., Hollinger, L. A., Wolpert, E. B., & Gardner, T. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23463 · Cited by 686
Self-citationIkenouchi, J., Matsuda, M., Furuse, M., & Tsukita, S. (2003) · Journal of Cell Science · doi:10.1242/jcs.00389 · Cited by 678
The 14-year incidence of visual loss in a diabetic population,
Moss, S. (1998) · Ophthalmology · doi:10.1016/s0161-6420(98)96025-0 · Cited by 672
Cited by
Items 101–200 of 410
Ai, X., Yu, P., Hou, Y., Song, X.-C., Luo, J., Li, N., Lai, X., Wang, X., & Meng, X. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110852 · Cited by 81
Feng, L., Li, W., Liu, Y., Jiang, W., Kuang, S., Wu, P., Jiang, J., Tang, L., Tang, W., Zhang, Y., et al. (2016) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2016.11.048 · Cited by 75
Claudin-5 Redistribution Induced by Inflammation Leads to Anti-VEGF–Resistant Diabetic Macular Edema
Arima, M., Nakao, S., Yamaguchi, M., Feng, H., Fujii, Y., Shibata, K., Wada, I., Kaizu, Y., Ahmadieh, H., Ishibashi, T., et al. (2020) · Diabetes · doi:10.2337/db19-1121 · Cited by 75
Yong, Y. K., Chiong, H. S., Somchit, M. N., & Ahmad, Z. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0901-3 · Cited by 73
Immunoengineering strategies to enhance vascularization and tissue regeneration
Zárubová, J., Hasani‐Sadrabadi, M. M., Ardehali, R., & Li, S. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114233 · Cited by 78
Yang, H., Tong, Z., Sun, S., & Mao, Z. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.024 · Cited by 68
Shi, H., Koronyo, Y., Fuchs, D.-T. S., Sheyn, J., Wawrowsky, K., Lahiri, S., Black, K. L., & Koronyo‐Hamaoui, M. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01076-4 · Cited by 72
Rigor, R. R., Beard, R. S., Litovka, O. P., & Yuan, S. Y. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00371.2011 · Cited by 67
TNF-α disrupts morphologic and functional barrier properties of polarized retinal pigment epithelium
Shirasawa, M., Sonoda, S., Terasaki, H., Arimura, N., Otsuka, H., Yamashita, T., Uchino, E., Hisatomi, T., Ishibashi, T., & Sakamoto, T. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.02.012 · Cited by 69
The role of reactive oxygen species in the pathogenesis and treatment of retinal diseases
Chan, T., Wilkinson‐Berka, J. L., Deliyanti, D., Hunter, D., Fung, A. T.-C., Liew, G., & White, A. J. R. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108255 · Cited by 76
Titchenell, P. M., & Antonetti, D. A. (2013) · Diabetes · doi:10.2337/db12-1744 · Cited by 70
Self-citationHuang, C., Wu, P., Jiang, W., Liu, Y., Zeng, Y.-Y., Jiang, J., Kuang, S., Tang, L., Zhang, Y., Zhou, X., et al. (2018) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2018.06.013 · Cited by 72
“7 cells, DON enhanced the secretion of TNF-α protein [29], and TNF-α down-regulated the protein content of ZO-1 and claudin-5 in bovine retinal endothelial cells [30].”
BackgroundTitchenell, P. M., Lin, C.-M., Keil, J. M., Sundstrom, J. M., Smith, C. D., & Antonetti, D. A. (2012) · Biochemical Journal · doi:10.1042/bj20111961 · Cited by 65
Self-citationDíaz-Coránguez, M., Lin, C., Liebner, S., & Antonetti, D. A. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011273 · Cited by 65
“Equal amounts of protein were prepared with NuPAGE LDS sample buffer (Thermo Fisher Scientific, NP0007) and NuPage sample-reducing agent (Thermo Fisher Scientific, NP0009), and Western blotting was carried out in a NuPAGE (Invitrogen, Thermo Fisher Scientific) system exactly as described (22).”
MethodSelf-citationPKCζ Mediates Breakdown of Outer Blood-Retinal Barriers in Diabetic Retinopathy
Omri, S., Béhar‐Cohen, F., Rothschild, P.-R., Gélizé, E., Jonet, L., Jeanny, J., Omri, B., & Crisanti, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081600 · Cited by 68
Giurdanella, G., Lazzara, F., Caporarello, N., Lupo, G., Anfuso, C. D., Eandi, C. M., Leggio, G. M., Drago, F., Bucolo, C., & Salomone, S. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.06.130 · Cited by 63
The EPAC–Rap1 pathway prevents and reverses cytokine-induced retinal vascular permeability
Ramos, C. J., Lin, C., Liu, X., & Antonetti, D. A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.815381 · Cited by 65
“TJ disruption may be mediated by VEGF-induced occludin phosphorylation (7), or TNF- – induced reduction in claudin-5 and ZO-1 expression (8) as well as currently uncharacterized mechanisms.”
BackgroundSelf-citationAryl hydrocarbon receptor utilises cellular zinc signals to maintain the gut epithelial barrier
Hu, X., Xiao, W., Lei, Y., Green, A., Lee, X., Maradana, M. R., Gao, Y., Xie, X., Wang, R., Chennell, G., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41168-y · Cited by 67
Mei, X., Zhang, T., Ouyang, H., Lü, B., Wang, Z., & Ji, L. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.11.011 · Cited by 63
Gustavsson, C., Agardh, C., & Agardh, E. (2012) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2012.02430.x · Cited by 62
Alkabie, S., Basivireddy, J., Zhou, L., Roskams, J., Rieckmann, P., & Quandt, J. A. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0657-9 · Cited by 63
McMahon, D., Oakden, W., & Hynynen, K. (2020) · Theranostics · doi:10.7150/thno.40908 · Cited by 68
Hang, H., Yuan, S., Yang, Q., Yuan, D., & Liu, Q. (2014) · Europe PMC (PubMed Central) · Cited by 58
Devi, T. S., Yumnamcha, T., Yao, F., Somayajulu, M., Kowluru, R. A., & Singh, L. P. (2019) · Biology Open · doi:10.1242/bio.038521 · Cited by 67
“This process, if prolonged, will cause lysosomal membrane permeabilization (LMP), cathepsin leakage, caspase-1 activation and a decrease in membrane tight junction proteins (Aveleira et al., 2010; Durchfort et al., 2012; Kauppinen et al., 2012; Zhuang et al., 2015).”
BackgroundKeep an eye on adenosine: Its role in retinal inflammation
Santiago, A. R., Madeira, M. H., Boia, R., Aires, I. D., Rodrigues‐Neves, A. C., Santos, P. F., & Ambrósio, A. F. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107513 · Cited by 62
Self-citationThe role of tight junction proteins in ovarian follicular development and ovarian cancer
Zhang, L., Feng, T., & SPICER, L. J. (2018) · Reproduction · doi:10.1530/rep-17-0503 · Cited by 57
Dominguez, J. M., Hu, P., Caballero, S., Moldovan, L., Verma, A., Oudit, G. Y., Li, Q., & Grant, M. B. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.01.023 · Cited by 57
Kwon, J. W., & Jee, D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203408 · Cited by 64
Neurotrophin receptor agonists and antagonists as therapeutic agents: An evolving paradigm
Josephy-Hernandez, S., Jmaeff, S., Pirvulescu, I., Aboulkassim, T., & Saragovi, H. U. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.08.004 · Cited by 54
Zhang, T., Mei, X., Ouyang, H., Lü, B., Yu, Z., Wang, Z., & Ji, L. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.11.006 · Cited by 55
Connexin43 hemichannel block protects against retinal pigment epithelial cell barrier breakdown
Kuo, C. Y. J., Green, C. R., Rupenthal, I. D., & Mugisho, O. O. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01352-3 · Cited by 54
Ferreira, L. B., Williams, K. A., Best, G., Haydinger, C. D., & Smith, J. R. (2023) · Clinical & Translational Immunology · doi:10.1002/cti2.1479 · Cited by 55
Proapoptotic and survival signaling in the neuroretina at early stages of diabetic retinopathy.
Valverde, Á. M., Miranda, S., García‐Ramírez, M., González‐Rodríguez, Á., Hernández, C., & Simó, R. (2013) · PubMed Central · Cited by 53
Inflammatory cytokine-specific alterations in retinal endothelial cell function
Palenski, T. L., Sorenson, C. M., & Sheibani, N. (2013) · Microvascular Research · doi:10.1016/j.mvr.2013.06.007 · Cited by 53
“TNF-α and IL-1β also increased bovine retinal EC permeability, while decreasing protein and mRNA content of tight junction proteins ZO-1 and claudin-5 (Aveleira et al., 2010).”
BackgroundInfluentialContribution of TNF receptor 1 to retinal neural cell death induced by elevated glucose
Costa, G. N., Vindeirinho, J., Cavadas, C., Ambrósio, A. F., & Santos, P. F. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.04.003 · Cited by 53
“…casting TNF-α as a major player in retinal cell death (Behl et al., 2008; Joussen et al., 2009) and also in inflammatory processes in DR, such as leukocyte recruitment (Gustavsson et al., 2010; Joussen et al., 2002; Limb et al., 1996) and increased vascular permeability (Aveleira et al., 2010).”
Self-citationNebbioso, M., Lambìase, A., Armentano, M., Tucciarone, G., Sacchetti, M., Greco, A., & Alisi, L. (2021) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2021.04.003 · Cited by 57
Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy
Crosby‐Nwaobi, R., Chatziralli, I., Sergentanis, T. Ν., Dew, T. K., Forbes, A., & Sivaprasad, S. (2015) · Journal of Diabetes Research · doi:10.1155/2015/191382 · Cited by 54
Peng, H., Luo, P., Li, Y., Wang, C., Liu, X., Ye, Z., Li, C., & Lou, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080009 · Cited by 52
Li, X.-X., Ling, S., Hu, M., Ma, Y., Li, Y., & Huang, P. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.09.015 · Cited by 55
Chandler, L. C., Barnard, A. R., Caddy, S. L., Patrício, M. I., McClements, M. E., Fu, H., Rada, C., MacLaren, R. E., & Xue, K. (2019) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2019.05.012 · Cited by 50
Nerve growth factor in diabetic retinopathy: beyond neurons
Mysona, B. A., Shanab, A. Y., Elshaer, S. L., & El‐Remessy, A. B. (2014) · Expert Review of Ophthalmology · doi:10.1586/17469899.2014.903157 · Cited by 53
Kady, N., Liu, X., Lydic, T. A., Syed, M., Navitskaya, S., Wang, Q., Hammer, S. S., O’Reilly, S., Huang, C., Seregin, S. S., et al. (2018) · Diabetes · doi:10.2337/db17-1034 · Cited by 51
“TJ protein staining at the cell border was quantified by semiquantitative ranking score system as previously described (5).”
BackgroundMethodSelf-citationChandler, L., Yusuf, I., McClements, M., Barnard, A., MacLaren, R., & Xue, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144972 · Cited by 49
Human Retinal Microvasculature‐on‐a‐Chip for Drug Discovery
Ragelle, H., Dernick, K., Khemais‐Benkhiat, S., Keppler, C., Cousin, L., Farouz, Y., Louche, C., Fauser, S., Kustermann, S., Tibbitt, M. W., et al. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202001531 · Cited by 51
Adachi, T., Teramachi, M., Yasuda, H., Kamiya, T., & Hara, H. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.01.014 · Cited by 50
Long-term Surveillance Following Intralesional Steroid Injection for Benign Vocal Fold Lesions
Wang, C., Lai, M., & Cheng, P. (2017) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2016.4418 · Cited by 48
Lu, Q., Chen, W., Li, L., Zheng, Z. J., & Xu, X. (2014) · PubMed · Cited by 52
Dalvi, P., Wang, K., Mermis, J. D., Zeng, R., Sanderson, M., Johnson, S. H., Dai, Y., Sharma, G., O'Brien-Ladner, A. R., & Dhillon, N. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085246 · Cited by 49
Macrophage migration inhibitory factor induces vascular leakage via autophagy
Chen, H., Chuang, Y., Chao, C.-H., & Yeh, T. (2015) · Biology Open · doi:10.1242/bio.201410322 · Cited by 50
Mechanisms of blood-retinal barrier disruption related to intraocular inflammation and malignancy
Tomkins‐Netzer, O., Niederer, R. L., Greenwood, J., Fabian, I. D., Serlin, Y., Friedman, A., & Lightman, S. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101245 · Cited by 47
“For example, treatment of retinal EC in vitro with TNF-α alters the TJ complex by decreasing the junctional expression of ZO-1 and claudin-5 through a PKC ζ /NF-κ B signalling pathway (Aveleira et al., 2010) or ZO-1 and occludin via the induction of iNOS (Palenski et al., 2013).”
BackgroundJariyapongskul, A., Areebambud, C., Suksamrarn, S., & Mekseepralard, C. (2015) · BioMed Research International · doi:10.1155/2015/785826 · Cited by 46
Organ-On-A-Chip Technologies for Advanced Blood–Retinal Barrier Models
Ragelle, H., Gonçalves, A., Kustermann, S., Antonetti, D. A., & Jayagopal, A. (2019) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2019.0017 · Cited by 49
Self-citationSilva, A. Y. O., Amorim, É. A., Barbosa-Silva, M. C., Lima, M. N., Oliveira, H. A., Granja, M. G., Oliveira, K. S., Fagundes, P. M., Neris, R. L. S., Campos, R. M. P., et al. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004219 · Cited by 43
“TNF-α is able to decrease levels of the tight junction protein claudin-5 and, in contrast, increase occludin content (41), events that were observed in our experiments, thus impairing BBB function (42).”
BackgroundShi, H., Yin, Z., Koronyo, Y., Fuchs, D.-T. S., Sheyn, J., Davis, M. R., Wilson, J. W., Margeta, M. A., Pitts, K. M., Herron, S., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01439-z · Cited by 46
Wang, Y., Sun, X., Xie, Y., Du, A., Chen, M., Lai, S., Wei, X., Ji, L., & Wang, C. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117135 · Cited by 59
Paul, A., Danley, M., Saha, B., Tawfik, O. W., & Paul, S. (2015) · Scientific Reports · doi:10.1038/srep12520 · Cited by 49
Sun, W., An, X., Zhang, Y., Zhao, X., Sun, Y., Yang, C., Kang, X., Jiang, L., Ji, H., & Lian, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1270145 · Cited by 49
Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina
Chandler, L. C., McClements, M. E., Yusuf, I. H., Martinez-Fernandez de la Camara, C., MacLaren, R. E., & Xue, K. (2021) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2021.05.011 · Cited by 43
“These molecules function to promote leukocyte recruitment, adhesion, and infiltration through the blood-retinal barrier, ultimately resulting in a breakdown of retinal immune privilege.(15,16)”
BackgroundRamos, H., Hernández, C., Simó, R., & Simó‐Servat, O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108796 · Cited by 47
Yli-Karjanmaa, M., Larsen, K. S., Fenger, C. D., Kristensen, L. K., Martin, N. A., Jensen, P. T., Breton, A., Nathanson, L., Nielsen, P. V., Lund, M. C., et al. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.08.195 · Cited by 41
“TNF secreted in an inflammatory environment decreases the expression of claudin-5 both in vivo and in vitro, thereby increasing BBB permeability (Aveleira et al., 2010; Dickstein et al., 2000; Forster et al., 2008; Nishioku et al., 2010).”
BackgroundWang, L., Wu, D., Fan, Z., Li, H., Li, J., Zhang, Y., Xu, Q., Wang, G., & Zhu, Z. (2020) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2020.05.039 · Cited by 46
Gong, X., & Rubin, L. P. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.02.004 · Cited by 43
Diabetic retinopathy: new therapeutic perspectives based on pathogenic mechanisms
Hernández, C., Simó-Servat, A., Bogdanov, P. M., & Simó, R. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0648-4 · Cited by 42
“TNF-α downregulates tight junction proteins of endothelial cells and plays en essential role in VEGF-induced leakage, thus participating to the breakdown of the BRB, which is the main pathogenic factor of DME [82].”
Beard, R. S., Hoettels, B. A., Meegan, J. E., Wertz, T. S., Cha, B. J., Yang, X., Oxford, J. T., Wu, M. H., & Yuan, S. Y. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18817512 · Cited by 41
Lu, Q., Li, L., Chen, W., Chen, H., Xu, X., & Zheng, Z. J. (2015) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-015-2985-3 · Cited by 43
Ni, J., Lin, M.-T., Jin, Y., Li, J., Guo, Y., Zhou, J., Hong, G., Zhao, G., & Lu, Z. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00662 · Cited by 42
“TNF-α increases bovine retinal endothelial cell (BREC) permeability through the protein kinase C (PKC) pathway in diabetic retinopathy (Aveleira et al., 2010).”
BackgroundThe Hierarchy of Proinflammatory Cytokines in Ocular Inflammation
Da Cunha, A. P., Zhang, Q., Prentiss, M., Wu, X. Q., Kainz, V., Xu, Y. Y., Vrouvlianis, J., Li, H., Rangaswamy, N., Leehy, B., et al. (2018) · Current Eye Research · doi:10.1080/02713683.2017.1410180 · Cited by 40
Ha, J., Shil, P. K., Zhu, P., Gu, L., Li, Q., & Chung, S. (2014) · Journal of Nutrition · doi:10.3945/jn.113.186957 · Cited by 42
Bogdanov, P. M., Sampedro, J., Solà-Adell, C., Simó‐Servat, O., Russo, C. A., Varela-Sende, L., Simó, R., & Hernández, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082458 · Cited by 40
Hernández, C., Bogdanov, P. M., Gómez‐Guerrero, C., Sampedro, J., Solà-Adell, C., Espejo, C., García‐Ramírez, M., Priéto, I., Egido, J., & Simó, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153615 · Cited by 40
“Abbreviations AGEs Advanced glucose end products BRB Blood-retinal barrier DME Diabetic macular edema DR Diabetic retinopathy ERG Electroretinogram GCL Ganglion cell layer GFAP Glial fibrillar acidic protein GLAST Glutamate-aspartate transporter JAKs Janus family of intracellular tyrosine kinases INL Inner nuclear lay…”
BackgroundInfluentialPatai, R., Csík, B., Nyúl‐Tóth, Á., Gulej, R., Kordestan, K. V., Chandragiri, S. S., Shanmugarama, S., Tarantini, S., Mukli, P., Ungvari, A., et al. (2025) · GeroScience · doi:10.1007/s11357-025-01569-x · Cited by 42
Serum and Aqueous Concentrations of Inflammatory Markers in Diabetic Macular Edema
Kocabora, M. S., Telli, M. E., Fazıl, K., Erdur, S. K., Özsütçü, M., Çekıç, O., & Özbilen, K. T. (2015) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2015.1034804 · Cited by 39
“TNF-a has also been shown to increase retinal vascular permeability by the alterations in the endothelial tight junction complex.(19) Etanercept, a soluble TNFa receptor inhibitor, has been reported to reduce vascular leukocyte adherence and blood–retinal barrier breakdown in the diabetic retina.”
BackgroundCamire, R. B., Beaulac, H. J., & Willis, C. L. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.05.008 · Cited by 37
The Correlation Between MicroRNAs and Diabetic Retinopathy
Zhao, X., Feng, L., Zhang, G. W., Yu, N., Yang, J., & Xin, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.941982 · Cited by 45
“Protein kinase C-z can be detected in endothelial cells and is involved in YYY- and VEGF-mediated cell proliferation and high permeability (81).”
BackgroundChen, D., Wei, X., Guan, J., Yuan, J.-W., Peng, Y.-T., Song, L., & Liu, Y. (2012) · Acta Neurochirurgica · doi:10.1007/s00701-012-1328-y · Cited by 38
“Several transcription factors such as the sex-determining region Y-box (SOX)−18 [14] and nuclear factor kappa B [2] have been identified to be able to regulate the expression of claudin-5.”
RetractedKeil, J. M., Liu, X., & Antonetti, D. A. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-11980 · Cited by 39
Self-citationJiang, M., Qin, C., & Han, M. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22352 · Cited by 37
“Inflammatory cytokines are the most probable suspects, and the results we obtained from the serum of breast tumorbearing mice authenticated that hypothesis [21].”
ResultWu, H., Brown, E. V., Acharya, N. K., Appelt, D. M., Marks, A., Nagele, R. G., & Venkataraman, V. (2016) · Brain Research · doi:10.1016/j.brainres.2016.02.026 · Cited by 38
Mohan, K. V., Mishra, A., Muniyasamy, A., Sinha, P., Sahu, P., Kesarwani, A., Jain, K., Nagarajan, P., Scaria, V., Agarwal, M., et al. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-022-02528-x · Cited by 37
Santos, F. M., Ciordia, S., Mesquita, J., Sousa, J. P. C., Paradela, A., Tomaz, C. T., & Passarinha, L. A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04670-y · Cited by 42
“Hyperglycemia-induced pathways [36, 220], hypoxic–ischemic conditions [221], and the activation of retinal glial cells, macrophages, and retinal neurons [222, 223] promote a pro-inflammatory environment that may disrupt the delicate balance of BRB. VEGF [224, 225], TNF-α [226], IL-1β [227], IGFBPs [228], ICAM-1 [111,…”
BackgroundInfluentialRearrangement of the cone mosaic in the retina of the rat model of retinitis pigmentosa
Ji, Y., Zhu, C. L., Grzywacz, N. M., & Lee, E. (2012) · Journal of Comparative Neurology · doi:10.1002/cne.22800 · Cited by 38
“Several past studies have reported on the role of cytokines on tight junction alteration in retina (Zech et al., 1998; Abe et al., 2003; Villarroel et al., 2009; Aveleira et al., 2010).”
BackgroundLi, W., Ma, N., Liu, M., Ye, B.-J., Li, Y., Hu, H., & Tang, Y. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.04.012 · Cited by 36
Zhao, H., Wang, Y., Yang, X., Fei, D., Mu, M., Guo, M., Yu, H., & Xing, M. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.09.069 · Cited by 36
Liu, Y., Meng, F., Wang, S., Xia, S., & Wang, R. (2021) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2021.108982 · Cited by 43
Sheemar, A., Soni, D., Takkar, B., Basu, S., & Venkatesh, P. (2021) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_1326_21 · Cited by 40
β‐Adrenergic receptor agonists attenuate pericyte loss in diabetic retinas through Akt activation
Yun, J., Jeong, H., Kim, K., Han, M. H., Lee, E. H., Lee, K., & Cho, C. (2017) · The FASEB Journal · doi:10.1096/fj.201700570rr · Cited by 36
Chang, K., & Petrash, J. M. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-98788-0_13 · Cited by 38
LRG1 as a novel therapeutic target in eye disease
Rossi, G. D., Lobo, M. E. D. V., Greenwood, J., & Moss, S. E. (2022) · Eye · doi:10.1038/s41433-021-01807-4 · Cited by 37
Pappa, V., Seydel, K. B., Gupta, S., Feintuch, C. M., Potchen, M. J., Kampondeni, S. D., Goldman-Yassen, A. E., Veenstra, M., Lopez, L., Kim, R. S., et al. (2015) · Malaria Journal · doi:10.1186/s12936-015-1036-1 · Cited by 35
Bogdanov, P. M., Solà-Adell, C., Hernández, C., García‐Ramírez, M., Sampedro, J., Simó‐Servat, O., Valeri, M., Pasquali, C., & Simó, R. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.07.009 · Cited by 38
Claudin 5 Across the Vascular Landscape: From Blood–Tissue Barrier Regulation to Disease Mechanisms
Selim, M. S., Matani, B. R., Henry-Ojo, H. O., Narayanan, S. P., & Somanath, P. R. (2025) · Cells · doi:10.3390/cells14171346 · Cited by 40
Szabadfi, K., Pintér, E., Reglődi, D., & Gabriel, R. (2014) · International review of cytology · doi:10.1016/b978-0-12-800179-0.00001-5 · Cited by 35
Zhang, D., Han, S., Wang, S., Luo, Y., Zhao, L., & Li, J. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13275 · Cited by 36
Wang, S., Meng, F., Liu, Y., Xia, S., & Wang, R. (2020) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2020.108911 · Cited by 36
Fong, L. Y., Ng, C. T., Zakaria, Z. A., Baharuldin, M. T. H., Arifah, A. K., Hakim, M. N., & Zuraini, A. (2015) · Phytotherapy Research · doi:10.1002/ptr.5404 · Cited by 33
“This is consistent with previous studies that demonstrated the apoptotic effect of TNF-α in endothelial cells (Aveleira et al., 2010; Petrache et al., 2001). n HAEC.”
ResultAbdullah, Z., & Bayraktutan, U. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.03.014 · Cited by 33
Yamaguchi, T., Shimizu, K., Kokubu, Y., Nishijima, M., Takeda, S., Ogura, H., & Kawabata, K. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222113 · Cited by 35
Lee, Y., & Yang, J. W. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111201 · Cited by 36
Imbalance of the Nerve Growth Factor and Its Precursor: Implication in Diabetic Retinopathy
Mohamed, R., & El‐Remessy, A. B. (2015) · Journal of Clinical & Experimental Ophthalmology · doi:10.4172/2155-9570.1000483 · Cited by 34
Metadata
- Authors
- Aveleira, C. A., Lin, C.-M., Abcouwer, S. F., Ambrósio, A. F., & Antonetti, D. A.
- Affiliations
- Pennsylvania State University (US)
- Centro de Neurociências e Biologia Celular (PT)
- Corresponding author
- Aveleira, Célia A.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2010-08-06
- Volume
- 59
- Issue
- 11
- Pages
- 2872-2882
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2963546
- OpenAlex
- W2155144135
- Cited by
- 403
- References
- 57
- Citations by year
- 2026: 18 · 2025: 25 · 2024: 17 · 2023: 26 · 2022: 31 · 2021: 33 · 2020: 34 · 2019: 35 · 2018: 35 · 2017: 31 · 2016: 23 · 2015: 29 · 2014: 17 · 2013: 21 · 2012: 20
- FWCI
- 9.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Juvenile Diabetes Research Foundation International
- University of Pennsylvania
- Pennsylvania State University
- National Institutes of Health (012021)
- Penn State College of Medicine
- National Eye Institute (R01EY012021, R01EY016413)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- TNF-α, IL-1β, tight junction proteins, ZO-1, claudin-5, protein kinase C, NF-κB signaling, dexamethasone, glucocorticoid receptor, IκBα, diabetic retinopathy, retinal vascular permeability, IKK inhibitor
- MeSH terms
- Protein Kinase C zeta, Animals, Cattle, Cell Membrane Permeability, Dexamethasone, Diabetic Retinopathy, Humans, Male, Permeability, Protein Kinase C, Retina, Retinal Diseases, Tumor Necrosis Factor-alpha, NF-kappa B, Rats, Sprague-Dawley, Tight Junctions, Endothelial Cells, Rats, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.